Tirzepatide
TirBaS
Eli Lilly · Phase 3 · Not yet recruiting · Enrollment 70
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Tirzepatide | Obesity or overweight | n/r | 52 | n/r | n/r |
| Placebo | Obesity or overweight | n/r | 52 | n/r | n/r |
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Tirzepatide
Eli Lilly · Phase 3 · Not yet recruiting · Enrollment 70
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Tirzepatide | Obesity or overweight | n/r | 52 | n/r | n/r |
| Placebo | Obesity or overweight | n/r | 52 | n/r | n/r |